{"id":"W4285806206","doi":"10.1016/j.jinorgbio.2022.111936","title":"Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET","year":2022,"lang":"en","type":"article","venue":"Journal of Inorganic Biochemistry","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; TRIUMF; University of British Columbia","funders":"National Research Council Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; University of Alberta","keywords":"Chemistry; Biodistribution; Conjugate; Bifunctional; Maleimide; Chelation; Trastuzumab; Conjugated system; Ligand (biochemistry); Combinatorial chemistry; In vivo; Amine gas treating; In vitro; Organic chemistry; Biochemistry; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001009231,0.0002020252,0.0001951846,0.00009840052,0.0001297236,0.000257807,0.0004259571,0.0003091266,0.001664195],"category_scores_gemma":[0.00008401005,0.00009849177,0.00009534524,0.000129381,0.000115683,0.0002055066,0.0002517634,0.0002151315,0.0004495307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002819427,"about_ca_system_score_gemma":0.0001361786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004376459,"about_ca_topic_score_gemma":0.0006577364,"domain_scores_codex":[0.9999266,0.00001122744,0.000003148889,0.00001526936,0.00001468941,0.00002918904],"domain_scores_gemma":[0.9999832,0.000002434536,0.000004486731,0.000001514273,0.000003536657,0.000004707573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001724439,0.00002155371,0.00009920808,0.000107978,0.000006742567,0.00008064699,0.00002087681,0.0002652759,0.9936406,0.0004543338,0.0003564014,0.004773897],"study_design_scores_gemma":[0.0000303586,0.0002539665,0.0004815562,0.000007343923,0.00002134868,0.0002396396,0.0000165745,0.002504866,0.9868434,0.0000576405,0.009534632,0.000008775319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792894,0.002451438,0.01064646,0.0002901084,0.00007239028,0.00005347966,0.0001858928,0.0002888471,0.006721906],"genre_scores_gemma":[0.9870369,0.0007541813,0.005331285,0.0001230807,0.00001520226,0.00002905131,0.0002053468,0.00002843219,0.006476436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001664195,"threshold_uncertainty_score":0.005567253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01699938367681642,"score_gpt":0.2915735892068444,"score_spread":0.274574205530028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}